Cardiac Sympathetic Hyperactivity after Chemotherapy: Early Sign of Cardiotoxicity?

BACKGROUND: Chemotherapy with anthracyclines and trastuzumab can cause cardiotoxicity. Alteration of cardiac adrenergic function assessed by metaiodobenzylguanidine labeled with iodine-123 ((123)I-mIBG) seems to precede the drop in left ventricular ejection fraction. OBJECTIVE: To evaluate and to co...

Descripción completa

Detalles Bibliográficos
Autores principales: Guimarães, Sarita Lígia Pessoa de Melo Machado, Brandão, Simone Cristina Soares, Andrade, Luciana Raposo, Maia, Rafael José Coelho, Markman Filho, Brivaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592170/
https://www.ncbi.nlm.nih.gov/pubmed/26176188
http://dx.doi.org/10.5935/abc.20150075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592170/
https://www.ncbi.nlm.nih.gov/pubmed/26176188
http://dx.doi.org/10.5935/abc.20150075

Ejemplares similares